Invesaro

Stocks Comparison

Park Ha Biological Technology vs PROCTER & GAMBLE: revenue, profit, margins and growth compared

Park Ha Biological Technology brought in $2.5M of revenue in fiscal 2025, PROCTER & GAMBLE $87B in fiscal 2026. Revenue changed by +6.0% at Park Ha Biological Technology and +3.3% at PROCTER & GAMBLE on the year before, so Park Ha Biological Technology grew faster. Park Ha Biological Technology kept -965.0% of its revenue as net profit, PROCTER & GAMBLE 18.4%. Free cash flow was -$3K at Park Ha Biological Technology and $15.1B at PROCTER & GAMBLE.

Side by side, latest fiscal year

BYAHPG
Fiscal year endedFY2025 (October 31, 2025)FY2026 (June 30, 2026)
Revenue$2.5M$87B
Revenue growth+6.0%+3.3%
Net income-$24.4M$16B
Net margin-965.0%18.4%
Free cash flow-$3K$15.1B
Free cash flow margin-0.1%17.4%
Earnings per share (diluted)-$41.38$6.62
Cash$3.8M$9.9B
Debtn/a$29.3B
Price to earningsn/a22.1
Market value$6.5M$339.9B
Dividend yieldn/a2.91%
Rank by revenue in sector#923 of 955 · Consumer discretionary#9 of 955 · Consumer discretionary

Over the years

Revenue
BYAH FY2022: $1.9MBYAH FY2024: $2.5MBYAH FY2024: $2.4MBYAH FY2025: $2.5MPG FY2019: $67.7BPG FY2020: $71BPG FY2021: $76.1BPG FY2022: $80.2BPG FY2023: $82BPG FY2024: $84BPG FY2025: $84.3BPG FY2026: $87BFY19FY20FY21FY22FY23FY24FY25FY26
BYAH $2.5MPG $87B
Net income
BYAH FY2022: $191.3KBYAH FY2024: $852KBYAH FY2024: $478.6KBYAH FY2025: -$24.4MPG FY2019: $3.9BPG FY2020: $13BPG FY2021: $14.3BPG FY2022: $14.7BPG FY2023: $14.7BPG FY2024: $14.9BPG FY2025: $16BPG FY2026: $16BFY19FY20FY21FY22FY23FY24FY25FY26
BYAH -$24.4MPG $16B
Net margin
BYAH FY2022: 10.0%BYAH FY2024: 34.6%BYAH FY2024: 20.1%BYAH FY2025: -965.0%PG FY2019: 5.8%PG FY2020: 18.4%PG FY2021: 18.8%PG FY2022: 18.4%PG FY2023: 17.9%PG FY2024: 17.7%PG FY2025: 19.0%PG FY2026: 18.4%FY19FY20FY21FY22FY23FY24FY25FY26
BYAH -965.0%PG 18.4%
Revenue growth
BYAH FY2024: +28.1%BYAH FY2024: -3.1%BYAH FY2025: +6.0%PG FY2020: +4.8%PG FY2021: +7.3%PG FY2022: +5.3%PG FY2023: +2.3%PG FY2024: +2.5%PG FY2025: +0.3%PG FY2026: +3.3%FY20FY21FY22FY23FY24FY25FY26
BYAH +6.0%PG +3.3%
Free cash flow
BYAH FY2022: $1.4MBYAH FY2024: $103.9KBYAH FY2024: $874.9KBYAH FY2025: -$3KPG FY2019: $11.9BPG FY2020: $14.3BPG FY2021: $15.6BPG FY2022: $13.6BPG FY2023: $13.8BPG FY2024: $16.5BPG FY2025: $14BPG FY2026: $15.1BFY19FY20FY21FY22FY23FY24FY25FY26
BYAH -$3KPG $15.1B

Fiscal years as each company reports them; the two may end in different months.

Questions about Park Ha Biological Technology and PROCTER & GAMBLE

Which is bigger by revenue, Park Ha Biological Technology or PROCTER & GAMBLE?

PROCTER & GAMBLE is bigger by revenue: $87B in fiscal 2026, against $2.5M for Park Ha Biological Technology in fiscal 2025.

Which keeps more of its revenue as profit, Park Ha Biological Technology or PROCTER & GAMBLE?

Park Ha Biological Technology had a net margin of -965.0% in fiscal 2025; PROCTER & GAMBLE had 18.4% in fiscal 2026.

Which grew revenue faster, Park Ha Biological Technology or PROCTER & GAMBLE?

In their latest fiscal years revenue changed by +6.0% at Park Ha Biological Technology and +3.3% at PROCTER & GAMBLE.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies